Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of investors of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) shares over potential securities laws violations by Eiger BioPharmaceuticals, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Eiger ...
You must register (for free) or login to view the entire investigation.